These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

382 related articles for article (PubMed ID: 17700237)

  • 1. What is new in the era of focal dystonia treatment? Botulinum injections and more.
    Cetinkaya A; Brannan PA
    Curr Opin Ophthalmol; 2007 Sep; 18(5):424-9. PubMed ID: 17700237
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Botulinum toxin for neurological disorders in a movement disorders clinic in Singapore.
    Tan AK
    Singapore Med J; 1998 Sep; 39(9):403-5. PubMed ID: 9885719
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Botulinum toxin in the treatment of dystonias--a hospital based study.
    Gupta M; Singh G; Khwaja G
    J Assoc Physicians India; 2003 May; 51():447-53. PubMed ID: 12974424
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and efficacy of botulinum toxin therapy in otorhinolaryngology: experience from 1,000 treatments.
    Helmstaedter V; Wittekindt C; Huttenbrink KB; Guntinas-Lichius O
    Laryngoscope; 2008 May; 118(5):790-6. PubMed ID: 18300708
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical application of botulinum toxin in otolaryngology, head and neck practice (brief review).
    Yin S; Stucker FJ; Nathan CO
    J La State Med Soc; 2001 Feb; 153(2):92-7. PubMed ID: 11261363
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Botulinum toxin treatment of hemifacial spasm and blepharospasm: objective response evaluation.
    Thussu A; Barman CR; Prabhakar S
    Neurol India; 1999 Sep; 47(3):206-9. PubMed ID: 10514580
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety, effectiveness, and duration of effect of BOTOX after switching from Dysport for blepharospasm, cervical dystonia, and hemifacial spasm dystonia, and hemifacial spasm.
    Bihari K
    Curr Med Res Opin; 2005 Mar; 21(3):433-8. PubMed ID: 15811212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dystonia, botulinum neurotoxin, and the aviator.
    Feinberg MJ
    Aviat Space Environ Med; 1999 Dec; 70(12):1235-7. PubMed ID: 10596783
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Progression of botulinum toxin type A dosage in craniocervical dystonias. An eight year comparative study].
    Echeverría Urabayen A; Fanjul S; Meseguer E; García Ruiz Espiga PJ
    Rev Neurol; 2004 Mar 16-31; 38(6):511-3. PubMed ID: 15054712
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectivity of Dysport in patients with blepharospasm and hemifacial spasm who experienced failure with Botox.
    Badarny S; Susel Z; Honigman S
    Isr Med Assoc J; 2008 Jul; 10(7):520-2. PubMed ID: 18751631
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Botulinum toxin management of upper facial rhytidosis and blepharospasm.
    Seiff SR; Zwick OM
    Otolaryngol Clin North Am; 2005 Oct; 38(5):887-902. PubMed ID: 16214565
    [No Abstract]   [Full Text] [Related]  

  • 12. Childhood-onset hemifacial spasm: successful treatment with botulinum toxin.
    Singer C; Papapetropoulos S; Farronay O
    Pediatr Neurol; 2005 Sep; 33(3):220-2. PubMed ID: 16139741
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Botulinum toxin A injections improve apraxia of eyelid opening without overt blepharospasm associated with neurodegenerative diseases.
    Kanazawa M; Shimohata T; Sato M; Onodera O; Tanaka K; Nishizawa M
    Mov Disord; 2007 Mar; 22(4):597-8. PubMed ID: 17266083
    [No Abstract]   [Full Text] [Related]  

  • 14. Supramaximal doses of botulinum toxin for refractory blepharospasm.
    Levy RL; Berman D; Parikh M; Miller NR
    Ophthalmology; 2006 Sep; 113(9):1665-8. PubMed ID: 16828511
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Riolan's muscle: action and indications for botulinum toxin injection.
    Mackie IA
    Eye (Lond); 2000 Jun; 14 ( Pt 3A)():347-52. PubMed ID: 11026998
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Botulinum toxin therapy for focal dystonia].
    Hahn K; Niklai E; Garzuly F; Szupera Z
    Orv Hetil; 2009 Jul; 150(29):1381-4. PubMed ID: 19581172
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blepharospasm and hemifacial spasm: a protocol for titration of botulinum toxin dose to the individual patient and for the management of refractory cases.
    Ortisi E; Henderson HW; Bunce C; Xing W; Collin JR
    Eye (Lond); 2006 Aug; 20(8):916-22. PubMed ID: 16531977
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Botulinum toxin A injections improve apraxia of eyelid opening without overt blepharospasm associated with neurodegenerative diseases.
    Lopez Valdes E; Posada Rodriguez IJ; Bilbao-Calabuig R
    Mov Disord; 2008 Apr; 23(5):773; author reply 773. PubMed ID: 18200601
    [No Abstract]   [Full Text] [Related]  

  • 19. Evaluating the effects of ice application on patient comfort before and after botulinum toxin type A injections.
    Saeliw P; Preechawai P; Aui-aree N
    J Med Assoc Thai; 2010 Oct; 93(10):1200-4. PubMed ID: 20973324
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adult-onset focal dystonias: presentation and treatment options.
    Esper GJ; Charles PD; Davis TL; Robertson D
    Tenn Med; 1997 Jan; 90(1):18-20. PubMed ID: 8997156
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.